Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising. Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a...
Taylor Wessing advised Shield Therapeutics on securing $26 million debt and equity fundraising. Shield Therapeutics plc, a specialty pharmaceutical company listed on AIM, has secured a...
You must be a Standard 1 Year member to access this content.